A Phase II Study of Bendamustine HCL [hydrochloride] in Relapsed and Primary Refractory Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Bendamustine (Primary) ; Pegfilgrastim
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 23 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jul 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 according to ClinicalTrials.gov record.
- 21 Jul 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2016 according to ClinicalTrials.gov record.